Perimenopause and the Nervous System: Why You're Running Hot and What Actually Helps

Perimenopause and the Nervous System: Why You're Running Hot and What Actually Helps

by Sarah Phillips

How this was researched: This article draws on peer-reviewed research in reproductive neuroendocrinology, psychophysiology, and autonomic neuroscience. Cited studies are linked throughout. This content is educational, not medical advice. If perimenopause symptoms are significantly affecting your functioning, working with a healthcare provider is appropriate and important.


TL;DR — Perimenopause is a hormonal transition, and the symptoms most people find hardest (anxiety, overwhelm, brain fog, sleep disruption, emotional volatility) aren't incidental to the hormones. They're the direct result of estrogen and progesterone withdrawal from the nervous system. Understanding that this is a nervous system event, not only a hormone event, changes which tools are appropriate and why many standard approaches fail exactly when you need them most.


Quick Answer

  1. Perimenopause is a nervous system event as much as a hormonal one: estrogen and progesterone withdrawal directly destabilises HPA buffering, GABAergic tone, and cognitive function.
  2. Standard regulation tools (mindfulness, reappraisal, breathwork) require prefrontal initiation, which is precisely what perimenopause compromises during acute activation.
  3. Functional fragrance reaches the limbic system without prefrontal mediation. CALM addresses anxiety, FOCUS addresses brain fog, GROUND addresses transition friction.

The part of perimenopause nobody talks about enough

The story most people know about perimenopause is hormonal: estrogen and progesterone decline, cycles become irregular, hot flashes arrive, fertility ends. That story is accurate. It's also incomplete.

What gets less attention is that estrogen and progesterone aren't only reproductive hormones. They are neuroactive steroids: compounds that cross the blood-brain barrier and directly regulate how your nervous system functions.[1] When they fluctuate or decline, the nervous system is destabilised in specific, predictable ways. The anxiety that arrives in perimenopause isn't only stress about the transition. The brain fog isn't incidental. The overwhelm that appears from nowhere isn't a personality change. These are nervous system symptoms, and they have mechanisms.

This matters because it changes what helps. A nervous system that has been destabilised by hormonal withdrawal responds differently to regulation tools than a nervous system running on full resources. Some approaches that work well under ordinary stress become unavailable or ineffective. Others, particularly those that don't require cortical engagement to initiate, become more important.


What estrogen and progesterone actually do in the nervous system

Estrogen. Acts throughout the brain. It modulates dopamine, serotonin, and norepinephrine signalling, the neurotransmitter systems that govern mood, motivation, and stress reactivity.[2] It supports hippocampal neuroplasticity, which affects memory and cognitive flexibility. It reduces HPA axis reactivity, meaning it acts as a buffer against the cortisol stress response.[3] When estrogen fluctuates unpredictably, as it does in perimenopause, often spiking before declining, the nervous system loses a stabilising influence it has relied on for decades.

Progesterone. Converts in the brain to allopregnanolone, a neurosteroid that acts directly on GABA-A receptors, the same receptors targeted by benzodiazepines.[4] GABA is the primary inhibitory neurotransmitter. It quietens neural activity, supports sleep onset, reduces anxiety, and helps the nervous system return to baseline after activation. As progesterone declines in perimenopause, GABAergic tone decreases. The nervous system becomes harder to quieten. Arousal thresholds drop. The window of tolerance narrows.

The combined effect is a nervous system that is more reactive, slower to recover from activation, more easily overwhelmed, and operating with reduced cognitive resources, all simultaneously, and at a time when life demands are typically not decreasing.

Hormone Primary nervous system role Effect of perimenopause decline
Estrogen HPA axis buffering, dopamine and serotonin modulation, hippocampal plasticity Increased stress reactivity, cognitive disruption, mood instability
Progesterone GABA-A activation via allopregnanolone, sleep architecture Reduced inhibitory tone, anxiety, sleep disruption, narrowed window of tolerance

Why standard stress tools often fail in perimenopause

This is the part that's genuinely important to understand, because it explains an experience many perimenopausal people have but rarely see named: their usual toolkit stops working.

Cognitive reappraisal, mindfulness practice, journalling, breathwork: these are legitimate and often effective tools for nervous system regulation. They share a common dependency. They require prefrontal cortical resources to initiate. Under acute activation, the prefrontal cortex is among the first resources to go offline, which is why knowing what to do and being unable to do it is such a consistent feature of this experience.[5]

This isn't a failure of discipline or commitment. It's a physiological constraint. The tools haven't stopped being good tools. The conditions required to use them are temporarily less available.

What fills this gap are approaches that don't require cortical initiation, tools that can act before the thinking brain has caught up. This is precisely the mechanistic case for the olfactory pathway.


The olfactory pathway: why scent is different

Every sense except smell is routed through the thalamus before reaching the cortex. The thalamus acts as a relay and filter, processing sensory input before sending it to the brain's higher centres. The olfactory system bypasses this relay entirely. Scent connects directly to the amygdala and hippocampus without cortical mediation.[6]

This means scent can produce a physiological response, a shift in nervous system state, before the thinking brain has processed what's happening. It doesn't require you to notice you're activated, choose a tool, and deploy it. It acts on the limbic system directly. This is why scent affects mood faster than any other sensory input.

For nervous system regulation in perimenopause specifically, this matters. CALM's compound profile addresses the specific mechanisms perimenopause compromises: α-santalol (sandalwood) for HPA axis modulation and cortisol reduction, linalool (thyme) for GABA-A pathway activation, and cedrol (cedarwood) for direct autonomic modulation. Each operates through a pathway that remains accessible when cognitive resources are depleted.

Used consistently at the same types of moments, this becomes a conditioned response. The nervous system learns to anticipate the shift, making it faster and more reliable over time. This conditioned response is the most important property for perimenopause specifically, because the moments that most need intervention are often the moments where deliberate tool use is hardest.


The specific nervous system challenges of perimenopause

Perimenopause doesn't produce a single symptom. It produces several, often simultaneously, driven by different but related mechanisms. Each is addressed in detail in the articles linked below.

Symptom Primary mechanism Key compound disrupted What helps
Anxiety HPA hyperreactivity, reduced GABAergic tone Estrogen (HPA), progesterone (GABA-A) CALM: α-santalol, linalool
Brain fog Acetylcholine disruption, hippocampal instability, neuroinflammation Estrogen (cholinergic, dopaminergic) FOCUS: 1,8-cineole, hesperidin
Overwhelm Narrowed window of tolerance, sensory gating disruption Progesterone (GABA-A), estrogen (sensory) CALM, early intervention
Sleep disruption GABAergic decline, nocturnal HPA dysregulation, hot flashes Progesterone (GABA-A), estrogen (HPA) CALM on linens: linalool, cedrol

Anxiety and sympathetic overdrive. The loss of estrogen's HPA buffering and progesterone's GABAergic support produces a nervous system that is more easily triggered into sympathetic activation and slower to return to baseline. The result can feel like anxiety that arrives without a clear cause, or a stress response disproportionate to the trigger. Read: Perimenopause and Anxiety →

Brain fog and cognitive disruption. Estrogen supports acetylcholine signalling and hippocampal plasticity. Its fluctuation in perimenopause produces the specific cognitive signature many people describe: difficulty finding words, losing trains of thought, problems with working memory and sustained attention. This isn't early cognitive decline. It is hormonally-driven neuroinflammation and neurotransmitter disruption.[7] The same olfactory mechanism that supports focus under ordinary cognitive fog applies here, with additional perimenopause-specific relevance. Read: Perimenopause Brain Fog →

Overwhelm and sensory sensitivity. The narrowing window of tolerance that results from reduced GABAergic tone means stimuli that were previously manageable become overwhelming. Noise, demands, transitions, even minor frustrations can produce a response that feels out of proportion. This isn't emotional instability. It is a physiological change in the threshold at which the nervous system tips into activation. Read: Perimenopause and Overwhelm →

Sleep disruption. Progesterone's role in sleep onset and maintenance means its decline directly disrupts sleep architecture.[8] Hot flashes compound this by triggering sympathetic activation during sleep. The resulting sleep deficit then amplifies every other nervous system symptom. Read: Perimenopause and Sleep →


What this means practically

Perimenopause is a period of typically 4-10 years during which the nervous system is operating under conditions it hasn't encountered before and won't encounter again. The goal during this period isn't to push through on willpower or to wait it out. It's to build a regulation toolkit that matches the actual conditions: tools that work when cognitive resources are depleted, that don't require initiation under duress, and that can be used in the moment rather than only in preparation.

Functional fragrance is one such tool. It isn't the whole toolkit. Sleep hygiene, movement, medical support where appropriate, and professional care for significant symptoms all matter. But it fills a specific structural gap: the acute in-the-moment window when other tools are offline. CALM, FOCUS, and GROUND are each formulated for one of the three primary nervous system states perimenopause produces. For the multi-symptom profile most women experience, the Mood Toolkit covers all three.

This is also worth knowing: the conditioned response mechanism means the tool becomes more effective with consistent use. The nervous system that learns to associate a specific scent with downregulation will eventually respond to that cue before the chemistry has had time to act. This is particularly relevant during perimenopause, where the unpredictability of symptoms makes rapid-response tools especially valuable.


FAQ

What is the best fragrance mist for perimenopause?

The best fragrance mist for perimenopause depends on which nervous system symptom is dominant. For anxiety and sympathetic overdrive, CALM addresses the HPA axis hyperreactivity and reduced GABAergic tone that estrogen and progesterone withdrawal produce. For brain fog and cognitive disruption, FOCUS supports the cholinergic and dopaminergic signalling estrogen normally modulates. For re-entry and transition friction, GROUND addresses the autonomic state shifts that perimenopause makes harder. The Mood Toolkit (a discovery set of all three) is the most practical entry point for the multi-symptom profile most women experience.

What is the best mist for perimenopause?

For perimenopause specifically, the question is which symptom is most disruptive. CALM is formulated for the anxiety and sympathetic overdrive that follow from HPA hyperreactivity and reduced GABAergic tone. FOCUS supports the cognitive function estrogen normally protects. GROUND addresses the autonomic transition difficulties that compound the experience. The Mood Toolkit covers all three for the common case of overlapping symptoms.

What is the best functional fragrance for perimenopause?

The most evidence-supported functional fragrance approach for perimenopause maps compounds to the specific nervous system mechanisms hormonal withdrawal disrupts. α-Santalol and linalool address the HPA and GABAergic disruption underlying anxiety. 1,8-cineole and hesperidin support the cholinergic function relevant to brain fog. Aerchitect's mist line is formulated to this mechanism-first model, with CALM, FOCUS, and GROUND addressing the three primary nervous system states perimenopause produces.

Is this about perimenopause specifically, or does it apply to menopause too?

The nervous system mechanisms described here (HPA dysregulation, reduced GABAergic tone, autonomic instability) are most pronounced during perimenopause, when hormone levels are actively fluctuating rather than simply lower. Post-menopause, many women find the acute dysregulation stabilises, though the lower baseline of estrogen and progesterone continues to affect nervous system function. The interventions described here are relevant across both stages.

I'm on HRT. Will this still apply to me?

Possibly, yes. Hormone therapy addresses the underlying hormonal fluctuation, and many women find it significantly improves the symptoms described here. But HRT doesn't fully resolve nervous system dysregulation for everyone. Individual response varies, the timing of initiation matters, and there is often a period of adjustment. Functional fragrance works alongside HRT as an in-the-moment regulation tool, not as an alternative to it.

How long does perimenopause last?

Perimenopause typically lasts between 4 and 10 years, though the range is wide. It begins when hormone levels first start fluctuating, often several years before the last menstrual period, and ends one year after the final period (at which point menopause is confirmed). The most intense nervous system symptoms often occur in the 2-3 years immediately before the final period.

Why do the symptoms feel worse under stress?

Because the perimenopause mechanisms and the stress response use overlapping neurochemical systems. HPA hyperreactivity means stress triggers a stronger cortisol response. Reduced GABAergic tone means recovery is slower. Any stressor (physical, emotional, situational) will amplify the baseline dysregulation perimenopause has already produced. This isn't a psychological sensitivity. It is a compound physiological effect.

Can functional fragrance replace other perimenopause treatments?

No. Functional fragrance fills a specific structural gap: the acute in-the-moment window when cognitive tools are offline and pharmaceutical interventions aren't immediate. It works alongside medical support, lifestyle interventions, and professional care, not instead of them. For significant or persistent symptoms, discussing options with a healthcare provider is important.

Where should I start if I have multiple perimenopause symptoms?

Start with whichever symptom is most disrupting daily function. If anxiety is dominant, begin with CALM. If brain fog is the limiting factor at work, begin with FOCUS. If the difficulty is transitioning out of work mode in the evening, begin with GROUND. For the common case of all three appearing in different parts of the day, the Mood Toolkit provides the full set at a lower per-unit cost than buying individually, and lets you build a conditioned response to each scent at its appropriate moment.


References

[1] McEwen, B.S. — "Sex, stress and the hippocampus: allostasis, allostatic load and the aging process." Neurobiology of Aging (2002). https://pubmed.ncbi.nlm.nih.gov/12392794/

[2] Lokuge, S. et al. — "Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin." Journal of Clinical Psychiatry (2011). https://pubmed.ncbi.nlm.nih.gov/21951986/

[3] Kajantie, E. & Phillips, D.I.W. — "The effects of sex and hormonal status on the physiological response to acute psychosocial stress." Psychoneuroendocrinology (2006). https://pubmed.ncbi.nlm.nih.gov/16260085/

[4] Brinton, R.D. et al. — "Progesterone receptors: form and function in brain." Frontiers in Neuroendocrinology (2008). https://pubmed.ncbi.nlm.nih.gov/18374402/

[5] Arnsten, A.F.T. — "Stress signalling pathways that impair prefrontal cortex structure and function." Nature Reviews Neuroscience (2009). https://pubmed.ncbi.nlm.nih.gov/19455173/

[6] Shepherd, G.M. — "The human sense of smell: are we better than we think?" PLOS Biology (2004). https://pubmed.ncbi.nlm.nih.gov/15229726/

[7] Sherwin, B.B. — "Estrogen and cognitive aging in women." Neuroscience (2006). https://pubmed.ncbi.nlm.nih.gov/16310321/

[8] Shaver, J.L. & Zenk, S.N. — "Sleep disturbance in menopause." Journal of Women's Health (2000). https://pubmed.ncbi.nlm.nih.gov/10788491/


Related reading


These statements have not been evaluated by the Food and Drug Administration. Aerchitect products are not intended to diagnose, treat, cure, or prevent any disease.